Apex Labs Files for US Patent Protecting Psychedelic Drug Delivery System03.07.24PR Newswire Read more
Apex Labs Applauds Senate Subcommittee’s Endorsement for Expanded Access to Psychedelic-Assisted Therapy for Veterans11.17.23Cision Read more
Canadian Veteran Dosed with First Cycle of APEX-90 Macrodose Psilocybin in Apex Labs’ Early Access Program.11.02.23Cision Read more
Canadian Veteran Receives Approval for APEX’s Psilocybin Therapy Through Health Canada’s Special Access Program10.05.23Cision Read more
Apex Labs announces the appointment of Chief Medical Officer & Chief Commercial Officer08.18.23Cision Read more
Apex Labs Receives Approval for US-Based Secondary GMP Psilocybin Supplier by Health Canada06.09.23Cision Read more
Apex Labs Granted Approval for 160 Patient Macrodose Multi-Dose Psilocybin Clinical Trial by Health Canada04.20.23Cision Canada Read more
Apex Labs Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Clinical Trial03.29.23Cision Read more
